The global Deflazacort Market is expanding steadily as healthcare providers seek effective corticosteroid solutions for complex inflammatory and neuromuscular disorders. Recognized for its potent anti-inflammatory and immunosuppressive capabilities, deflazacort plays a critical role in managing conditions including Duchenne Muscular Dystrophy (DMD) and other chronic inflammatory diseases. A recent report by The Insight Partners indicates that the market’s growth is being driven by clinical research developments, technological advancements, and changing population demographics. Read more - https://www.theinsightpartners.com/reports/deflazacort-market